Concepedia

Charles Widström

CW

Statistics

Publications

21

Citations

2K

H-Index

21

Active since

2000

Affiliations

Uppsala University(Current)

Uppsala University Hospital

Affibody (Sweden)

KTH Royal Institute of Technology

Hospital Sírio-Libanês

Charles Widström is an author at Uppsala University specializing in medicine, tumor biology, and cancer research.

Top concepts

Publications per year

2000–2017

21

Publications

21

Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule

Anna Orlova, Mikaela Magnusson, Tove Eriksson et al. · Cancer Research · 2006 · 555 citations · Full text

Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing <sup>177</sup>Lu-DOTA-Octreotate Treatment

Mattias Sandström, Ulrike Garske‐Román, Silvia Johansson et al. · Journal of Nuclear Medicine · 2012 · 275 citations · Full text

Targeting of HER2-Expressing Tumors with a Site-Specifically <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecule, Z<sub>HER2:2395</sub>, with C-Terminally Engineered Cysteine

Sara Ahlgren, Helena Wållberg, Thuy Tran et al. · Journal of Nuclear Medicine · 2009 · 113 citations · Full text

111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.

Vladimir Tolmachev, Fredrik Nilsson, Charles Widström et al. · PubMed · 2006 · 111 citations

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence

Torun Engfeldt, Anna Orlova, Thuy Tran et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 99 citations

, , +13

1–5 of 21